Abstract
Objective: To evaluate the prevalence of M. genitalium infection among pregnant women attending in a Primary Health Unit (PHU) in the city of Manaus. and assess the patients' epidemiological profile. Methods: This was a prevalence study involving 242 pregnant women, using RT-PCR testing for STIs in vaginal secretions. Epidemiological data were collected from medical records of patients previously selected to participate in a pilot project aimed at expanding STI testing during prenatal care, in partnership with the Ministry of Health and the municipal health department. Results: M. genitalium was detected in 7.9% of the pregnant women, with higher prevalence observed in young, single women with a history of injectable and non-injectable drug use, and co-infection with syphilis. Obstetric variable analysis did not show a significant association with the infection, although prevalence was higher in the third trimester of pregnancy. Conclusion: M. genitalium is often asymptomatic, with higher prevalence in at-risk groups, highlighting the importance of targeted screening and prevention strategies to prevent obstetric and neonatal complications. Furthermore, future research is needed to identify more effective treatments.
References
ASENJO A, et al. Mycoplasma genitalium in Spain: prevalence of genital infection and frequency of resistance to macrolides. Enfermedades Infecciosas y Microbiología Clínica, 2018; 36(3): 169-171.
BISSESSOR M, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clinical Infectious Diseases, 2015; 60: 1228-1236.
CUNHA GKP. Infecção por micoplasma genital e o desfecho de parto pré-termo: coorte BRISA. Dissertação (Mestrado em Ginecologia e Obstetrícia – Biologia da Reprodução) – Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, 2021; 98.
DONDERS GGG, et al. Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen. Journal of Perinatal Medicine, 2017; 45(5): 505-515.
GETMAN D, et al. Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States. Journal of Clinical Microbiology, 2016; 54(9): 2278-2283.
JENSEN JS, et al. European guideline on Mycoplasma genitalium infections. Journal of the European Academy of Dermatology and Venereology, 2016; 30: 1650-1656.
LANNOY LH, et al. Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecções que causam corrimento uretral. Epidemiologia e Serviços de Saúde, 2021; 30(1).
LILLIS RA, et al. Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans. Clinical Infectious Diseases, 2019; 69(3): 459-465.
LIS R, et al. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clinical Infectious Diseases, 2015; 61(3): 418-426.
LUKI N, et al. Comparison of polymerase chain reaction assay with culture for detection of genital mycoplasmas in perinatal infections. European Journal of Clinical Microbiology & Infectious Diseases, 1998; 17(4): 255-263.
MA C, et al. The associations of genital mycoplasmas with female infertility and adverse pregnancy outcomes: a systematic review and meta-analysis. Reproductive Sciences, 2021; 28(11): 3013-3031.
MANHART LE, et al. Characteristics of Mycoplasma genitalium Urogenital Infections in a Diverse Patient Sample from the United States: Results from the Aptima Mycoplasma genitalium Evaluation Study (AMES). Journal of Clinical Microbiology, 2020; 58(7): 165-20.
MENA LA, et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clinical Infectious Diseases, 2009; 48: 1649-1654.
MENEZES ME, et al. Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States. Journal of Clinical Microbiology, 2016; 54(9): 2278-2283.
MIRANDA AE, et al. Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium and risk factors among pregnant women in Brazil: Results from the national molecular diagnosis implementation project. Int J Gynaecol Obstet, 2024; 166(1): 71-79.
RAJKUMARI N, et al. Association of Mycoplasma genitalium with infertility in North Indian women. Indian Journal of Sexually Transmitted Diseases and AIDS, 2015; 36: 144-148.
SCOULLAR MJL, et al. Mycoplasma genitalium in pregnancy, including specific co-infections, is associated with lower birthweight: a prospective cohort study. Med, 2024; 5(9): 1123-1136.3.
SMOLARCZYK K, et al. The impact of selected bacterial sexually transmitted diseases on pregnancy and female fertility. International Journal of Molecular Sciences, 2021; 22(4): 2170.
STAFFORD IA, et al. Retrospective analysis of infection and antimicrobial resistance patterns of Mycoplasma genitalium among pregnant women in the southwestern USA. BMJ Open, 2021; 11: 50475.
TAYLOR-ROBINSON D. Mycoplasma genitalium -- an update. International Journal of STD & AIDS, 2002; 13(3): 145-151.
VALLELY LM, et al. Adverse pregnancy and neonatal outcomes associated with Neisseria gonorrhoeae, Mycoplasma genitalium, M. hominis, Ureaplasma urealyticum and U. parvum: a systematic review and meta-analysis protocol. BMJ Open, 2018; 8(11): 24175.
WELCH HM. The polymerase chain reaction. Methods Mol Biol, 2012; 878: 71-88.
WORKOWSKI KA, et al. Sexually transmitted infections treatment guidelines. MMWR Recommendations and Reports, 2021; 70(4): 1-187.
XIANG Z, et al. Risk factors for Mycoplasma genitalium infection among female sex workers: a cross-sectional study in two cities in southwest China. BMC Public Health, 2012; 12: 414.
